Interim analysis of the long-term efficacy and safety of azetukalner in an ongoing open-label extension study following a phase 2b clinical trial (X-TOLE) in adults with focal epilepsy - French, J A; Porter, R J; Perucca, E; X-TOLE Study Group (Epilepsia Open, 2025)